Radiance targets brachytherapy to heart bypass population
This article was originally published in Clinica
Executive Summary
Radiance Medical Systems could become the first company to test a catheter-based radiation treatment for restenosis in US heart bypass patients, a population that represents a large but as yet untapped segment of the vascular brachytherapy market.